Introduction Clinical practice guidelines based on best available evidence and national safety and quality standards promote high quality and safe care.

Aim To review and standardise systemic anti-cancer therapy (SACT) forms in a 20-chair cancer centre to reflect Australian and international clinical practice guidelines.

Method A pre–post audit design based on Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of systemic cancer therapy underpinned the project. The pre-audit (47 forms) provided a benchmark for SACT form improvements: 177 new forms were then developed over 18 months and implemented.

Results Pre-audit: 9/19 criteria were >70% compliant with best practice guidelines. Post-SACT implementation audit: 15/19 criteria were >70% compliant. The recent 2018 audit: improvements shown in 18/19 criteria.

Conclusion This nurse-led multidisciplinary initiative effectively standardised SACT charts with best practice guidelines, potentially reducing serious medication errors and facilitating a high standard of multidisciplinary patient care.

Aim To identify experiences of young cancer survivors and their perception of optimal components of survivorship care and wellness programs.

Background Most young people survive their cancer diagnosis and are then at risk for long-term negative consequences. Survivorship care is important, but there is little evidence to inform optimal service models.

Methods Semi-structured interviews were conducted with adolescents and young adults (15–24 years). Content analysis was used to identify themes.

Results Sixteen young people participated. Three major themes are described: concerns after treatment; after treatment services; and perceptions of a wellness survivorship program. Within each theme, further subthemes highlighted the difficulties young people face when trying to return to normal life. Fear of cancer recurrence and a need for greater coordination of support and services were the highest concerns.

Conclusions: Findings highlight the need for an individualised approach to survivorship care that engages and empowers young people as partners in their own healthcare.

Background Epidermal growth factor receptor inhibitors (EGFRI) cause skin toxicity in the majority of patients who receive them. Evidence-based guidelines aim to reduce the severity and duration of skin toxicity which causes physical discomfort and impacts negatively on patients’ quality of life.

Methods A pre/post-audit design was utilised at an ambulatory cancer care centre in a tertiary metropolitan hospital. Data were collected and audited from January 2018 to December 2019.

Results Documentation for 16 patients was reviewed against best practice recommendations. Barriers to evidence implementation and strategies to improve supportive care were identified and implemented. A post-implementation audit of 13 patients demonstrated that implementation strategies improved the delivery of supportive care.

Conclusion Targeted nurse education and dermatological toxicity-specific documentation are effective strategies for improving the implementation of evidence-based supportive care for patients with EGFRI skin toxicity.